Summary & Overview
CPT 90702: DT Vaccine (Diphtheria and Tetanus) for Children
CPT code 90702 denotes the DT (diphtheria and tetanus) vaccine administered intramuscularly for children younger than 7 years. This childhood immunization code is a core component of pediatric preventive care and immunization schedules nationally, supporting protection against two serious bacterial diseases. The code matters to providers and payers because accurate coding ensures appropriate vaccine tracking, coverage determination, and public health reporting.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on clinical context and common sites of service, along with benchmarking and policy-relevant considerations where available. The publication outlines coding clarity for immunization billing, highlights payer coverage scope, and summarizes typical clinical settings for administration.
This summary equips clinicians, billing staff, and policy analysts with a clear understanding of what CPT code 90702 represents, why it is used in pediatric immunization programs, and which major payers are relevant for coverage discussions. Data not available in the input are noted where applicable in detailed sections.
Billing Code Overview
CPT code 90702 represents a DT vaccine product administered intramuscularly to protect against diphtheria and tetanus. This vaccine formulation is intended for children younger than 7 years of age.
Service Type: Immunization / Vaccine administration
Typical Site of Service: Outpatient clinics, pediatric offices, public health clinics, and other ambulatory care settings where childhood immunizations are provided.
Clinical & Coding Specifications
Clinical Context
A 3-year-old child is brought to a pediatric primary care clinic for routine immunizations per the CDC childhood schedule. The child is generally well, with up-to-date well-child visit documentation, parental consent for immunization, and no contraindications such as severe allergic reaction to a prior DT-containing vaccine. The nurse verifies patient identity, reviews the immunization record, screens for acute illness and allergies, and documents informed consent. The DT vaccine is administered intramuscularly in the anterolateral thigh using age-appropriate technique and a single-dose syringe. Post-vaccination observation for 15 minutes is performed to monitor for immediate adverse reactions. Documentation includes vaccine product, lot number, expiration date, anatomical site, route (IM), dose, administrator identity, and vaccine information statement provided. Billing is submitted using 90702 for the DT vaccine for children under 7 years; a visit or evaluation code may be reported separately if clinically appropriate and supported by documentation. Typical sites of service include pediatric primary care offices, community health clinics, public health departments, and walk-in immunization clinics.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no other modifier applies; default reporting. |